• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肿瘤抑制因子ARF的抗病毒作用。

Antiviral action of the tumor suppressor ARF.

作者信息

García María A, Collado Manuel, Muñoz-Fontela César, Matheu Ander, Marcos-Villar Laura, Arroyo Javier, Esteban Mariano, Serrano Manuel, Rivas Carmen

机构信息

Centro Nacional de Biotecnología (CNB), Universidad Autónoma de Madrid, Madrid, Spain.

出版信息

EMBO J. 2006 Sep 20;25(18):4284-92. doi: 10.1038/sj.emboj.7601302. Epub 2006 Sep 7.

DOI:10.1038/sj.emboj.7601302
PMID:16957780
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1570439/
Abstract

Oncogenic viruses frequently target the pathways controlled by tumor suppressor genes, suggesting an extra function for these proteins as antiviral factors. The control exerted by the tumor suppressor Arf on cellular proliferation is crucial to restrict tumor development; however, a potential contribution of Arf to prevent viral infectivity has remained unexplored. In the present study, we investigated the consequences of loss or increased expression of Arf on viral infection. Our results reveal that ARF expression is induced by interferon and after viral infection. Furthermore, we show that ARF protects against viral infection in a gene dosage-dependent manner, and that this antiviral action is mediated in part by PKR through a mechanism that involves ARF-induced release of PKR from nucleophosmin complexes. Finally, Arf-null mice were hypersensitive to viral infection compared to wild-type mice. Together, our results reveal a novel and unexpected role for the tumor suppressor ARF in viral infection surveillance.

摘要

致癌病毒经常靶向由肿瘤抑制基因控制的通路,这表明这些蛋白质作为抗病毒因子具有额外功能。肿瘤抑制因子Arf对细胞增殖的控制对于限制肿瘤发展至关重要;然而,Arf在预防病毒感染方面的潜在作用仍未得到探索。在本研究中,我们研究了Arf缺失或表达增加对病毒感染的影响。我们的结果表明,ARF表达由干扰素诱导并在病毒感染后出现。此外,我们表明ARF以基因剂量依赖的方式保护细胞免受病毒感染,并且这种抗病毒作用部分由PKR介导,其机制涉及ARF诱导PKR从核磷蛋白复合物中释放。最后,与野生型小鼠相比,Arf基因缺失的小鼠对病毒感染高度敏感。总之,我们的结果揭示了肿瘤抑制因子ARF在病毒感染监测中具有意想不到的新作用。

相似文献

1
Antiviral action of the tumor suppressor ARF.肿瘤抑制因子ARF的抗病毒作用。
EMBO J. 2006 Sep 20;25(18):4284-92. doi: 10.1038/sj.emboj.7601302. Epub 2006 Sep 7.
2
p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.p19(ARF)在体内致癌应激诱导的p53介导的细胞凋亡和肿瘤抑制过程中并非必需。
Mol Cell Biol. 2002 Jan;22(1):370-7. doi: 10.1128/MCB.22.1.370-377.2002.
3
The Arf tumor suppressor gene promotes hyaloid vascular regression during mouse eye development.Arf肿瘤抑制基因在小鼠眼睛发育过程中促进玻璃体血管消退。
Proc Natl Acad Sci U S A. 2002 Mar 19;99(6):3848-53. doi: 10.1073/pnas.052484199. Epub 2002 Mar 12.
4
Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice.Ink4a和Arf对Bmi1基因缺陷小鼠的细胞增殖和神经干细胞自我更新有不同影响。
Genes Dev. 2005 Jun 15;19(12):1438-43. doi: 10.1101/gad.1299305.
5
Identification of novel ARF binding proteins by two-hybrid screening.通过双杂交筛选鉴定新型ARF结合蛋白。
Cell Cycle. 2006 Mar;5(6):641-6. Epub 2006 Mar 15.
6
Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.E2F3对Arf肿瘤抑制因子的抑制作用是正常细胞周期动力学所必需的。
Genes Dev. 2004 Jun 15;18(12):1413-22. doi: 10.1101/gad.1196704. Epub 2004 Jun 2.
7
The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.p16(INK4a) 或 p19(ARF) 缺陷对细胞生长和肿瘤发生的差异影响。
Oncogene. 2004 Jan 15;23(2):379-85. doi: 10.1038/sj.onc.1207074.
8
Loss of Bax alters tumor spectrum and tumor numbers in ARF-deficient mice.Bax缺失改变了ARF缺陷小鼠的肿瘤谱和肿瘤数量。
Cancer Res. 2002 Apr 1;62(7):2184-91.
9
The Arf tumor suppressor regulates platelet-derived growth factor receptor beta signaling: a new view through the eyes of Arf(-/-) mice.Arf肿瘤抑制因子调节血小板衍生生长因子受体β信号传导:通过Arf基因敲除小鼠获得的新观点。
Cell Cycle. 2005 Oct;4(10):1316-9. doi: 10.4161/cc.4.10.2109. Epub 2005 Oct 17.
10
p16Ink4a or p19Arf loss contributes to Tal1-induced leukemogenesis in mice.p16Ink4a或p19Arf缺失促成小鼠中Tal1诱导的白血病发生。
Oncogene. 2006 May 18;25(21):3023-31. doi: 10.1038/sj.onc.1209326.

引用本文的文献

1
SUMOylation of the lysine-less tumor suppressor p14ARF counters ubiquitylation-dependent degradation.无赖氨酸肿瘤抑制因子p14ARF的类泛素化修饰可对抗泛素化依赖性降解。
Cell Death Dis. 2025 Jul 12;16(1):519. doi: 10.1038/s41419-025-07854-z.
2
Chromatin environment-dependent effects of DOT1L on gene expression in male germ cells.DOT1L对雄性生殖细胞基因表达的染色质环境依赖性影响。
Commun Biol. 2025 Jan 28;8(1):138. doi: 10.1038/s42003-024-07393-x.
3
Sex-related differences in delayed doxorubicin-induced cardiac dysfunction in C57BL/6 mice.C57BL/6 小鼠中阿霉素延迟性心脏功能障碍的性别相关差异。
Arch Toxicol. 2024 Apr;98(4):1191-1208. doi: 10.1007/s00204-023-03678-y. Epub 2024 Jan 20.
4
The ARF tumor suppressor targets PPM1G/PP2Cγ to counteract NF-κB transcription tuning cell survival and the inflammatory response.ARF 肿瘤抑制因子靶向 PPM1G/PP2Cγ,以拮抗 NF-κB 转录调节细胞存活和炎症反应。
Proc Natl Acad Sci U S A. 2020 Dec 22;117(51):32594-32605. doi: 10.1073/pnas.2004470117. Epub 2020 Dec 7.
5
Therapeutic Targeting of Signaling Pathways Related to Cancer Stemness.针对癌症干性相关信号通路的治疗靶向作用
Front Oncol. 2020 Aug 26;10:1533. doi: 10.3389/fonc.2020.01533. eCollection 2020.
6
Uncovering Tumour Heterogeneity through PKR and nc886 Analysis in Metastatic Colon Cancer Patients Treated with 5-FU-Based Chemotherapy.通过对接受基于5-氟尿嘧啶化疗的转移性结肠癌患者进行PKR和nc886分析揭示肿瘤异质性
Cancers (Basel). 2020 Feb 7;12(2):379. doi: 10.3390/cancers12020379.
7
Signal Transduction in Ribosome Biogenesis: A Recipe to Avoid Disaster.核糖体生物发生中的信号转导:避免灾难的秘诀。
Int J Mol Sci. 2019 Jun 3;20(11):2718. doi: 10.3390/ijms20112718.
8
Rescue of Expression Is Not Sufficient to Rescue Spermiogenic Phenotype of Mice with Deletions of Y Chromosome Long Arm.挽救 Y 染色体长臂缺失小鼠的精子发生表型,单纯表达是不够的。
Genes (Basel). 2019 Feb 12;10(2):133. doi: 10.3390/genes10020133.
9
Cell senescence is an antiviral defense mechanism.细胞衰老(老化)是一种抗病毒防御机制。
Sci Rep. 2016 Nov 16;6:37007. doi: 10.1038/srep37007.
10
Emerging roles of p53 and other tumour-suppressor genes in immune regulation.p53及其他肿瘤抑制基因在免疫调节中的新作用。
Nat Rev Immunol. 2016 Dec;16(12):741-750. doi: 10.1038/nri.2016.99. Epub 2016 Sep 26.

本文引用的文献

1
Resistance to viral infection of super p53 mice.超级p53小鼠对病毒感染的抵抗力
Oncogene. 2005 Apr 21;24(18):3059-62. doi: 10.1038/sj.onc.1208477.
2
Tumour biology: senescence in premalignant tumours.肿瘤生物学:癌前肿瘤中的细胞衰老
Nature. 2005 Aug 4;436(7051):642. doi: 10.1038/436642a.
3
Regulation of NF-kappaB and p53 through activation of ATR and Chk1 by the ARF tumour suppressor.通过ARF肿瘤抑制因子激活ATR和Chk1对核因子κB和p53进行调控。
EMBO J. 2005 Mar 23;24(6):1157-69. doi: 10.1038/sj.emboj.7600608. Epub 2005 Mar 10.
4
Modulation of the ARF-p53 pathway by the small DNA tumor viruses.小DNA肿瘤病毒对ARF-p53信号通路的调控
Cell Cycle. 2005 Mar;4(3):449-52. doi: 10.4161/cc.4.3.1555. Epub 2005 Mar 24.
5
Increased gene dosage of Ink4a/Arf results in cancer resistance and normal aging.Ink4a/Arf基因剂量增加可导致抗癌能力和正常衰老。
Genes Dev. 2004 Nov 15;18(22):2736-46. doi: 10.1101/gad.310304. Epub 2004 Nov 1.
6
ARF impedes NPM/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway.急性肾衰竭在一种对小鼠双微体2敏感的肿瘤抑制途径中阻碍核仁磷酸蛋白/B23穿梭。
Mol Cell Biol. 2004 Nov;24(21):9327-38. doi: 10.1128/MCB.24.21.9327-9338.2004.
7
Human tumor suppressor p53 and DNA viruses.人类肿瘤抑制因子p53与DNA病毒。
Rev Med Virol. 2004 Sep-Oct;14(5):301-19. doi: 10.1002/rmv.431.
8
p19Arf suppresses growth, progression, and metastasis of Hras-driven carcinomas through p53-dependent and -independent pathways.p19Arf通过p53依赖和非依赖途径抑制Hras驱动的癌的生长、进展和转移。
PLoS Biol. 2004 Aug;2(8):E242. doi: 10.1371/journal.pbio.0020242. Epub 2004 Aug 17.
9
Different requirements for the cytostatic and apoptotic effects of type I interferons. Induction of apoptosis requires ARF but not p53 in osteosarcoma cell lines.I型干扰素对细胞生长抑制和凋亡作用的不同要求。在骨肉瘤细胞系中,凋亡的诱导需要ARF而不是p53。
J Biol Chem. 2004 Jul 30;279(31):32275-80. doi: 10.1074/jbc.M313830200. Epub 2004 May 28.
10
Telomere maintenance requires the RAD51D recombination/repair protein.端粒维持需要RAD51D重组/修复蛋白。
Cell. 2004 Apr 30;117(3):337-47. doi: 10.1016/s0092-8674(04)00337-x.